Revatis is a Belgian spin-off from the University of Liege, dedicated to regenerative medicine and cell therapy. The company has a patented technology for obtaining multipotent stem cells from muscle micro-biopsies. Revatis produces autologous stem cells for veterinary medicine (horses and companion animals) and positions itself as a supplier of personalized stem cells for human medicine research, organ-on-a-chip, and 3D bioprinting. It operates with GMP-certified production in aseptic isolators.
muscle-derived mesenchymal stem cells, autologous cell therapy, veterinary regenerative medicine, GMP stem cell production, organ-on-a-chip applications
1 site worldwide
No certifications on file yet.
No reviews available yet.
No documents available.